Disclosed is a method of inducing sleep in a human suffering from a sleeping disorder comprising administering to the human a therapeutically effective amount of cetirizine hydrochloride once daily. Also disclosed is pharmaceutical compositions concerning the same.
CROSS REFERENCE TO RELATED APPLICATION
The following application is a continuation of, and claims benefit of priority pursuant to 35 U.S.C. .sctn.120 to U.S. patent application Ser. No. 09/688,313, filed on Oct. 13, 2000, now U.S. Pat. No. 6,258,814.
The present invention is directed to a method for treating symptoms associated with Restless Legs Syndrome (RLS). The method includes administering to a warm-blooded animal in need of such treatment a dose of ketamine sufficient to alleviate symptoms associated with RLS.
